Misplaced Pages

Spondyloperipheral dysplasia

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Spondyloperipheral dysplasia" – news · newspapers · books · scholar · JSTOR (August 2020) (Learn how and when to remove this message)
Medical condition
Spondyloperipheral dysplasia
Other namesSpondyloperipheral dysplasia-short ulna syndrome
Spondyloperipheral dysplasia has an autosomal dominant pattern of inheritance.

Spondyloperipheral dysplasia is an autosomal dominant disorder of bone growth. The condition is characterized by flattened bones of the spine (platyspondyly) and unusually short fingers and toes (brachydactyly). Some affected individuals also have other skeletal abnormalities, short stature, nearsightedness (myopia), hearing loss, and mental retardation. Spondyloperipheral dysplasia is a subtype of collagenopathy, types II and XI.

Genetics

Spondyloperipheral dysplasia is one of a spectrum of skeletal disorders caused by mutations in the COL2A1 gene, located on chromosome 12q13.11-q13.2. The protein made by this gene forms type II collagen, a molecule found mostly in cartilage and in the clear gel that fills the vitreous humour (the eyeball). Type II collagen is essential for the normal development of bones and other connective tissues (the tissues that form the body's supportive framework).

Mutations in the COL2A1 gene interfere with the assembly of type II collagen molecules. The protein made by the altered COL2A1 gene cannot be used to make type II collagen, resulting in a reduced amount of this type of collagen in the body. Instead of forming collagen molecules, the abnormal protein builds up in cartilage cells (chondrocytes). These changes disrupt the normal development of bones, leading to the signs and symptoms of spondyloperipheral dysplasia.

The disorder is believed to be inherited in an autosomal dominant manner. This indicates that the defective gene responsible for the disorder is located on an autosome (chromosome 12 is an autosome), and only one copy of the defective gene is sufficient to cause the disorder, when inherited from a parent who has the disorder.

Diagnosis

This section is empty. You can help by adding to it. (August 2017)

Management

This section is empty. You can help by adding to it. (August 2017)

References

  1. ^ Zabel, B.; Hilbert, K.; Stöß, H.; Superti-Furga, A.; Spranger, J.; Winterpacht, A. (May 1996). "A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia". American Journal of Medical Genetics. 63 (1): 123–128. doi:10.1002/(SICI)1096-8628(19960503)63:1<123::AID-AJMG22>3.0.CO;2-P. PMID 8723097.
  2. Online Mendelian Inheritance in Man (OMIM): 120140

This article incorporates public domain text from Spondyloperipheral dysplasia at NLM Genetics Home Reference

External links

ClassificationD
External resources
Diseases of collagen, laminin and other scleroproteins
Collagen disease
COL1:
COL2:
COL3:
COL4:
COL5:
COL6:
COL7:
COL8:
COL9:
COL10:
COL11:
COL12:
COL17:
COL18:
Laminin
Other
see also fibrous proteins
Categories:
Spondyloperipheral dysplasia Add topic